Publication: Accounting for genetic heterogeneity in homozygosity mapping: Application to Mendelian susceptibility to mycobacterial disease
dc.contributor.author | Grant, Audrey V. | |
dc.contributor.author | Dupuis, Stephanie Boisson | |
dc.contributor.author | Herquelot, Eleonore | |
dc.contributor.author | de Beaucoudrey, Ludovic | |
dc.contributor.author | Santos, Orchidee Filipe | |
dc.contributor.author | Nolan, Daniel K. | |
dc.contributor.author | Feinberg, Jacqueline | |
dc.contributor.author | Boland, Anne | |
dc.contributor.author | Al-Muhsen, Saleh | |
dc.contributor.author | Sanal, Özden | |
dc.contributor.author | Çamcıoğlu, Yıldız | |
dc.contributor.author | Palanduz, Ayşe | |
dc.contributor.author | Bustamante, Jacinta | |
dc.contributor.author | Casanova, Jean-Laurent | |
dc.contributor.author | Abel, Laurent | |
dc.contributor.buuauthor | Kılıç, Sara Şebnem | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0001-8571-2581 | tr_TR |
dc.contributor.researcherid | AAH-1658-2021 | tr_TR |
dc.contributor.scopusid | 34975059200 | tr_TR |
dc.date.accessioned | 2022-03-16T07:52:08Z | |
dc.date.available | 2022-03-16T07:52:08Z | |
dc.date.issued | 2011-08 | |
dc.description.abstract | Introduction Genome-wide homozygosity mapping is a powerful method for locating rare recessive Mendelian mutations. However, statistical power decreases dramatically in the presence of genetic heterogeneity. Methods The authors applied an empirical approach to test for linkage accounting for genetic heterogeneity by calculating the sum of positive per-family multipoint LOD scores (S) across all positions, and obtaining corresponding empirical p values (EmpP) through permutations. Results The statistical power of the approach was found to be consistently higher than the classical heterogeneity LOD by simulations. Among 21 first-cousin matings with a single affected child, for five families linked to a locus of interest and 16 families to other loci, S/EmpP achieved a power of 40% versus 28% for heterogeneity LOD at an alpha level of 0.001. The mean size of peak linkage regions was markedly higher for true loci than false positive regions. The S/EmpP approach was applied to a sample of 17 consanguineous families with Mendelian susceptibility to mycobacterial disease, leading to the identification of two mutations in IL12RB1 and TYK2 from the largest of six linkage regions at p<10(-3). Conclusions The S/EmpP approach is a flexible and powerful approach that can be applied to linkage analysis of families with suspected Mendelian disorders. | en_US |
dc.description.sponsorship | Schlumberger | de |
dc.description.sponsorship | Institut Universitaire de France | fre |
dc.description.sponsorship | European Commission (QLK2-CT-2002-0046) | en_US |
dc.description.sponsorship | Rockefeller University Center for Clinical and Translational Science (5UL1RR024143) | en_US |
dc.description.sponsorship | Rockefeller University | en_US |
dc.description.sponsorship | Bill & Melinda Gates Foundation | en_US |
dc.description.sponsorship | St Giles Foundation | en_US |
dc.description.sponsorship | Jeffrey Modell Foundation and Talecris Biotherapeutics | en_US |
dc.description.sponsorship | National Institute of Allergy and Immunology (1R01AI089970) | en_US |
dc.description.sponsorship | Fondation pour la Recherche Medicale | fre |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Center for Research Resources (NCRR) (UL1RR024143) | en_US |
dc.description.sponsorship | United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of Allergy & Infectious Diseases (NIAID) (R01AI089970) | en_US |
dc.description.sponsorship | National Center for Research Resources (UL1RR024143) | en_US |
dc.identifier.citation | Grant, A. V. vd. (2011). "Accounting for genetic heterogeneity in homozygosity mapping: Application to Mendelian susceptibility to mycobacterial disease". Journal of Medical Genetics, 48(8), 567-571. | en_US |
dc.identifier.endpage | 571 | tr_TR |
dc.identifier.issn | 0022-2593 | |
dc.identifier.issue | 8 | tr_TR |
dc.identifier.pubmed | 21572128 | tr_TR |
dc.identifier.scopus | 2-s2.0-79961127020 | tr_TR |
dc.identifier.startpage | 567 | tr_TR |
dc.identifier.uri | https://doi.org/10.1136/jmg.2011.089128 | |
dc.identifier.uri | https://jmg.bmj.com/content/48/8/567 | |
dc.identifier.uri | http://hdl.handle.net/11452/25068 | |
dc.identifier.volume | 48 | tr_TR |
dc.identifier.wos | 000292958800012 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bmj Publishing Group | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Journal of Medical Genetics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Genetics & heredity | en_US |
dc.subject | Sequencing-based discovery | en_US |
dc.subject | Deficiency | en_US |
dc.subject | Immunity | en_US |
dc.subject | Mutation | en_US |
dc.subject | Reveals | en_US |
dc.subject.emtree | Interleukin 12 receptor beta1 | en_US |
dc.subject.emtree | Protein kinase TYK2 | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Family | en_US |
dc.subject.emtree | Gene locus | en_US |
dc.subject.emtree | Gene mapping | en_US |
dc.subject.emtree | Gene mutation | en_US |
dc.subject.emtree | Gene sequence | en_US |
dc.subject.emtree | Genetic association | en_US |
dc.subject.emtree | Genetic linkage | en_US |
dc.subject.emtree | Genetic susceptibility | en_US |
dc.subject.emtree | Genotype | en_US |
dc.subject.emtree | Homozygosity | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Immune deficiency | en_US |
dc.subject.emtree | Mendelian susceptibility to mycobacterial disease | en_US |
dc.subject.emtree | Mycobacteriosis | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Single nucleotide polymorphism | en_US |
dc.subject.mesh | Family | en_US |
dc.subject.mesh | Genetic heterogeneity | en_US |
dc.subject.mesh | Genetic predisposition to disease | en_US |
dc.subject.mesh | Genome-wide association study | en_US |
dc.subject.mesh | Homozygote | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Lod Score | en_US |
dc.subject.mesh | Mycobacterium infections | en_US |
dc.subject.scopus | Mycobacteriosis; Deficiency; BCG Vaccine | en_US |
dc.subject.wos | Genetics & heredity | en_US |
dc.title | Accounting for genetic heterogeneity in homozygosity mapping: Application to Mendelian susceptibility to mycobacterial disease | en_US |
dc.type | Article | |
dc.wos.quartile | Q1 | en_US |
dspace.entity.type | Publication |